Immune Group

مادة اعلانية

Latest Update: 24 Apr 2025 14:10 Abu Dhabi Time.

Market Status: Closed

MCGS

Immune Group

4.62

QAR

-0.016

-0.35%

Open

4.62

Prev Close

4.64

PX_VOLUME

283,887

MARKET CAP (M)

DAY RANGE

4.59 - 4.62

52 WEEKS

3.90 - 4.82

Stock Statistics

Yearly Change

14.07%

Listed Shares (Million)

281.44

Earnings Multiple

21.00

Average 30-day trading volume

1,206,716.88

Price-to-book ratio

1.27

Earnings Per Share

0.33

Previous Dividend Distribution

0.20

Dividend Yield

4.29%

Financial Summary

Quarterly
Annual

Income Statements

	Period Ending:	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023
Total Revenue		127.75	141.06	123.54	128.79	130.07	129.96	109.24
Gross Profit		40.16	44.85	44.92	44.91	42.28	38.44	35.52
Operating Income		20.28	23.01	23.54	23.84	22.47	17.20	17.02
Profit Margin		16.92	17.03	20.03	19.89	17.33	13.30	15.61

	Period Ending:	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Total Revenue		523.49	485.96	487.17	483.63	476.80
Gross Profit		175.67	156.12	160.95	160.43	161.84
Operating Income		83.78	70.34	75.04	77.23	83.09
Profit Margin		17.99	15.69	16.25	16.35	17.93

Balance Sheet

	Period Ending:	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023
Total Assets		1,416.78	1,412.78	1,395.20	1,371.24	1,364.86	1,346.17	1,348.12
Total Liabilities		389.99	403.65	407.92	414.63	336.30	333.71	334.32
Total Equity		1,026.79	1,009.14	987.28	956.61	1,028.56	1,012.46	1,013.80

	Period Ending:	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Total Assets		1,412.78	1,346.17	1,357.07	1,337.51	1,316.80
Total Liabilities		403.65	333.71	316.87	307.56	288.57
Total Equity		1,009.14	1,012.46	1,040.20	1,029.95	1,028.23

Cash Flows Statements - Coming Soon

* In Million of Qatar Riyal

Reminder: The financial information on this website is delayed information that are originates from certified data providers in the financial markets, who retain the rights and intellectual property of this data, absolving ADMN of any responsibility.